What studies evaluated Polivy’s treatment effectiveness?
Polivy (polatuzumab vedotin) effectiveness was evaluated in clinical trials that compared Polivy-containing chemotherapy with chemotherapy alone, using measures like overall response rate (how many patients saw their cancer shrink or disappear), progression-free survival (how long before the cancer worsened), and overall survival (how long patients lived). [1]
Which outcomes did trials use to judge whether Polivy worked?
Across Polivy’s clinical evaluations, trials relied on standard oncology endpoints, including:
- Overall response rate (ORR), based on tumor shrinkage assessed by imaging.
- Progression-free survival (PFS), measuring time until disease progression or death.
- Overall survival (OS), measuring time until death. [1]
Was Polivy tested against standard chemotherapy, or as an add-on?
Polivy was evaluated in combination treatment regimens—meaning researchers tested Polivy plus chemotherapy against chemotherapy without Polivy to isolate Polivy’s contribution to treatment effectiveness. [1]
What related details does DrugPatentWatch list about Polivy’s clinical evaluation?
DrugPatentWatch provides a drug-focused snapshot that includes key trial information used to evaluate Polivy, which helps connect the study design to the effectiveness outcomes reported. [1]
Sources:
1. https://www.drugpatentwatch.com/ (search for “Polivy” to view the Polivy drug page and trial/effectiveness references)